Organigram Global Inc. Overview
Pro stress-test →Organigram is Canada's #1 cannabis company by market share, operating as a licensed cultivator and processor of high-quality cannabis products. The company is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships. The company has achieved significant growth momentum with double-digit revenue expansion and expanding US presence.
Strategic Profile
Pro stress-test →Organigram holds #1 market share in Canada across vapes, milled flower, and concentrates, with leading positions in pre-rolls and edibles. The company has launched its Collective Project and Fetch brands into Illinois and Wisconsin through new distribution partners, expanding its US retail footprint to 11 states. The company demonstrates strong operational execution with a diverse brand portfolio and increasing focus on US expansion and cannabinoid beverage markets.
Competitive Landscape
Pro stress-test →The Canadian cannabis market is dominated by Organigram, which faces competition from established players like Canopy Growth and Tilray/Aphria. In the US market, Organigram competes through its Collective Project and Fetch brands across 11 states. The competitive landscape is intensifying as US hemp-derived THC and federal regulatory changes create new opportunities and threats.
Industry Context
Organigram Global Inc. operates in Cannabis Production & Distribution.
Key facts
Founded: 2013 · Headquarters: Moncton, New Brunswick · Revenue: $63.5M (Q1 FY2026 net revenue) · Market cap: N/A